Category: Science & Technology Posted: May 11, 2012 09:40AM Author: Guest_Jim_*

Whoever first had the idea for the lithography system used to produce modern integrated circuits, probably did not think their invention would be used to clean a person's blood. As reported by the American Institute of Physics, researchers at MIT and the National University of Singapore have created a device that cleans infections from the blood. The key was using margination, a natural phenomenon that separates parts of the blood.

As your blood flows through your blood vessels, white blood cells and bacteria move towards the wall of the vessel, while the red blood cells flow through the middle. The researchers decided to try making a device that replicates this effect. By etching microfluidic channels just 20 micrometers (millionths of a meter: m) by 20 m into a polymer chip, the researchers successfully removed at least 80% of the E. coli bacteria, yeast, and other inflammatory components from a blood sample.

Potentially this technology could be used to treat sepsis, a dangerous and systemic inflammatory response to blood infections. First small-scale in vivo animal tests have to be successful, but this is definitely a promising and interesting way to clean ones blood.

See more here:
Nanotechnology for Cleaning Blood

In his visit to Albany Tuesday, President Barack Obama highlighted the nanotechnology initiatives in Upstate New York as the foundation for a new era in American manufacturing.

He spoke at the Albany College of Nanoscale Science and Engineering, which is partnering with SUNYIT in Marcy to make New York a center for computer technology businesses and research.

The reason I came here today is because this school and this community represent the future of our economy, Obama said. Right now, some of the most advanced manufacturing work in America is being done right here in Upstate New York. Cutting-edge businesses from all over the world are deciding to build here and hire here.

Click here for entire speech.

SUNYIT President Wolf Yeigh, who attended the event, said Obama had hit it right on.

He said bring these outsourced jobs back to America, and it is happening right there in Albany, Yeigh said. He mentioned that semiconductors are the next wave of American greatness. The Mohawk Valley is poised to be on that wave.

Albany's nanotechnology sector was jump-started in the mid-1990s, as state dollars were poured into the College of Nanoscale Science and Engineering. It has been growing ever since.

SUNYIT was brought into the mix in 2009, when state Assembly Speaker Sheldon Silver and other state officials announced $45 million to create a Computer Chip Commercialization Center and Center for Advanced technology.

Then, in September of 2011, $4.4 billion in government and private sector investments in nanotechnology statewide were announced. SUNYIT also is set to gain from that windfall.

All told, more than 900 jobs, many of them well paid, are expected to land in the Mohawk Valley, officials have said.

Link:
Obama in Albany: CNY enters new era with nanotechnology

Pakistan's spike in nanotech research publications has been hit by funds crunch.

Flickr/nic221

[KARACHI] Nanotechnology research in Pakistan, which had shown a trend of higher publication numbers over the last decade, has suffered from the countrys present financial crisis, a study said.

In 2008 the government did not extend the term of the National Commission for Nanoscience and Technology, initially set up in 2003 for three years and later extended for two more years.

The study, published online on 29 March in Scientometrics, said research publications in the field had grown from seven in 2000 to an impressive 542 papers in 2011, registering a 29 per cent annual growth rate.

This is higher than the average annual growth rate of 23 per cent registered globally, said Rizwan Sarwar Bajwa, research associate at the Preston Institute of Nanoscience and Technology in Islamabad who, together with his colleague Khwaja Yaldram, had carried out the study.

Much of the contribution came from 13 universities while only two state-owned research and development institutions in the country participated in nanoscience and nanotechnology research.

The study attributed the spurt in research and publications to heavy government spending on manpower training and procuring the latest equipment for laboratories working in the field.

"Unfortunately, the present financial crunch faced by the country could have a negative impact on the progress achieved so far," the study concluded.

"The publication shows that despite availability of funding, the research and development institutes contributed very little in the field of nanoscience and nanotechnology," Bajwa, lead author of the study, told SciDev.Net.

Read the original here:
Funds crunch hits Pakistan’s surge in nanotech research

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/ths3db/nanotechnology_for) has announced the addition of the "Nanotechnology for Drug Delivery: Global Market for Nanocrystals" report to their offering.

Nanocrystals will account for 60% of a $136 billion nanotechnology-enabled drug delivery market by 2021. We forecast the total market size in 2021 to be US$136 billion, with a 60/40 split between nanocrystals and nanocarriers respectively.

Since we now understand that most (if not all) biological processes occur at the nanoscale, the application of life science principles - studying the causes of biological phenomena at the molecular level - means that medical and biomedical research is increasingly using a bottom-up (rather than the top-down) approach.

The healthcare market is changing. The author is seeing a paradigm shift away from blockbusters and a one-size fits all' approach to a more personalised medicine based on an individual's unique genome and immune response. The more scientists learn about the molecular causes for disease the more targeted and effective nanotechnology-enabled drug delivery therapies will become.

Nanocrystals will outperform nanocarriers by 20%

Nanocrystal-based drugs showed the highest market growth in the last decade compared to other nanotechnology-enabled drug delivery systems studied, according to Cientifica Ltd.'s latest research. This is largely due to the shorter development times and smaller investment needed to create nanocrystals. The report presents a detailed discussion of recent developments (2000-2010) in nanocrystal therapies and future opportunities (2011-2021).

The low bioavailability resulting from traditional oral (both tablet and liquid) drug delivery methods and the market forces at work in the pharmaceutical industry - where patents expire after a relatively short period of time unless a novel form of drug delivery is developed that will extend the patent - are two major forces that will fuel the growth of the nanotech enabled drug delivery market, said Harper.

The National Science Foundation has forecast the global nanotech-enabled market will reach US$1 trillion by 2015, while the National Nanotechnology Initiative predicts it will reach US$3 trillion by 2020. Drug nanocrystals would therefore account for approximately 2.5% of the total global nanotechnology market in 2015 and 3.5% in 2021.

For more information visit http://www.researchandmarkets.com/research/ths3db/nanotechnology_for

View original post here:
Research and Markets: Nanotechnology for Drug Delivery: Global Market for Nanocrystals - Drug Nanocrystal Market Will ...

Mississauga nanotechnology developer and manufacturer Integran Technologies Inc. has received a repayable loan of nearly $400,000 from the federal government for a new development project. The company is developing nano-structured aerospace and defence products. The money will be used to create "next-generation metal alloys that are more robust and free from toxic beryllium copper," which will help expand the company's product line and its customer base. Industry Minister Christian Paradis said the money will come from the Strategic Aerospace and Defence Initiative, which supports industrial research and development projects in the aerospace, defence, space and security industries. "By investing in innovative firms like Integran, our government is ensuring that Canada's aerospace and defence industry remains a global leader and continues to be a major contributor to our economy," said Paradis. "This support will allow Integran to realize new market opportunities in an emerging market segment." As part of the initiative, Integran will work with graduate-level engineering students from the University of Toronto. "Since being founded over 12 years ago, Integran has been committed to developing environmentally benign alternatives to toxic materials and processes," said company president and chief executive officer Gino Palumbo. "Integran is confident that through this program, our core patented nanotechnology can be optimized and demonstrated to be a viable, cost-effective alternative to the alloying of copper with toxic beryllium - a strengthening process that remains in widespread use for various industrial, aerospace and defence applications." cclay@mississauga.net

Muslim clothing store opens

Fatma Nurmohamed says it will no longer be a chore for Muslim women to find western-inspired, Muslim clothing that still meets their needs of modesty in Mississauga.

The rest is here:
Nanotechnology firm receives nearly $400K

May 3, 2012 - U.S. FDA has issued 2 draft guidance documents that address use of nanotechnology by food and cosmetics industries. According to FDA, food draft guidance describes factors manufacturers should consider when determining whether changes in manufacturing processes, including those involving nanotechnology, create significant change in identity, safety, or regulatory status of food substance. Cosmetic draft guidance discusses safety assessment of nanomaterials when used in cosmetic products. American National Standards Institute (ANSI) 25 West 43rd Street, 4th Floor New York, NY, 10036 USA Press release date: April 26, 2012

The U.S. Food and Drug Administration (FDA) - a member of the American National Standards Institute (ANSI) - has issued two draft guidance documents that address the use of nanotechnology by the food and cosmetics industries.

As coordinator of the U.S. standardization system, ANSI invites any interested U.S. stakeholder to review the files and submit their comments directly to FDA by July 24, 2012.

According to FDA, the food draft guidance describes the factors manufacturers should consider when determining whether changes in manufacturing processes, including those involving nanotechnology, create a significant change in the identity, safety, or regulatory status of the food substance. The cosmetic product draft guidance discusses the FDA's current thinking on the safety assessment of nanomaterials when used in cosmetic products.

Both documents encourage manufacturers to consult with the agency before taking their products to market. Such consultation can help FDA experts address questions related to the safety or other attributes of nanotechnology products, or answer questions about their regulatory status.

"Understanding nanotechnology remains a top FDA priority. FDA is strengthening the scientific tools and methods for evaluating food products, cosmetics, drugs and medical devices," said FDA Commissioner Margaret A. Hamburg, M.D. "We are taking a prudent scientific approach to assess each product on its own merits and to not make broad, general assumptions about the safety of nanotechnology products."

FDA has also published a nanotechnology fact sheet.

Instructions for submitting comments can be found in the following Federal Register notices:

Draft Guidance for Industry: Assessing the Effects of Significant Manufacturing Process Changes, Including Emerging Technologies, on the Safety and Regulatory Status of Food Ingredients and Food Contact Substances, Including Food Ingredients That Are Color Additives; Availability

Draft Guidance for Industry: Safety of Nanomaterials in Cosmetic Products; Availability

Original post:
FDA Seeks Comment on Draft Guidance on Use of Nanotechnology by Food and Cosmetics Industries

Just four months after the National Nanotechnology Initiative (NNI) responded to the Presidents Council of Advisors on Science and Technologys (PCAST) 2010 report on the status of nanotechnology, PCAST has offered up a new assessment.

While thePCAST report on the NNI in 2010 wanted to see greater efforts towards commercialization and some attempt to address environmental, health and safety (EHS) concerns, this time they just wanted to see how well the NNI had done in meeting their previous recommendations.

In the Whitehouse.gov blog covering the announcement it seems PCAST are satisfied:

PCAST found that the Federal agencies in the NNI have made substantial progress in addressing many of the 2010 recommendations that were aimed at maintaining U.S. leadership in nanotechnology The PCAST assessment particularly commends the expanded efforts of the NNCO in the area of commercialization and coordination with industry, and the NNCOs release of a focused research strategy for addressing environmental, health, and safety (EHS) implications of nanotechnology.

Okay, pat on the back, job well doneuh, wait, there are still some new recommendations that PCAST would like to see addressed. You can find them in the PDF of the full report on page vii. They fall into the areas of strategic planning, program management, metrics for assessing nanotechnologys commercial and societal impacts, andwait for itincreased support for EHS research.

Additional support for EHS research might be a required element for every PCAST report in the future. More interesting to me, however, is this continued emphasis on improved metrics for assessing nanotechnologys commercial and societal impacts.

It seems to me that this is an area in which everyone from governments to corporations wants a formula that will churn out a sense of what kind of impact nanotechnology is really having. While nobody is satisfied with the metrics that we have, I would suggest that there are few number-counting options that will really be able to sort out the full impact of nanotechnology. But again, it should be interesting to see what they come up with.

Continued here:
President's Council Wants a Few More Things from the National Nanotechnology Initiative

Public release date: 1-May-2012 [ | E-mail | Share ]

Contact: Adriana Bobinchock abobinchock@partners.org 617-855-2110 McLean Hospital

Belmont, MA - Researchers at Harvard-affiliated McLean Hospital have shown a new category of "green" nanoparticles comprised of a non-toxic, protein-based nanotechnology that can non-invasively cross the blood brain barrier and is capable of transporting various types of drugs.

In an article published May 1, 2012 online in PLoS ONE, Gordana Vitaliano, MD, director of the Brain Imaging NaNoTechnology Group at the McLean Hospital Imaging Center, reported that clathrin protein, a ubiquitous protein found in human, animal, plant, bacteria and fungi cells, can been modified for use as a nanoparticle for in-vivo studies. "Clathrin has never been modified for use in vivo and offers many new and interesting possibilities for delivering drugs and medical imaging agents into the brain", said Vitaliano.

Clathrin is the body's primary delivery vehicle responsible for delivering many different types of molecules into cells. Vitaliano therefore believed that the protein's naturally potent transport capabilities might be put to practical medical use for drug delivery and medical imaging.

"This study provides a new insight into utilizing bioengineered clathrin protein as a novel nanoplatform that passes the blood brain barrier," said Vitaliano, who successfully attached different fluorescent labels, commonly used in imaging, to functionalize clathrin nanoparticles. "We were able to show that the clathrin nanoparticles could be non-invasively delivered to the central nervous system (CNS) in animals. The clathrin performed significantly."

Of major importance for future clinical applications, Vitaliano also showed that clathrin crossed and/or bypassed the blood-brain barrier without enhancers or modifications, unlike other nanoparticles. These findings open the door to exploring new and important CNS medical applications.

One important medical application for clathrin nanoparticles would be Magnetic Resonance Imaging (MRI). Gadolinium contrast agents are often used to improve MRI performance. In one configuration, Vitaliano found that functionalized clathrin nanoparticles performed 8,000 times better than an FDA approved MRI contrast agent (gadopentetate dimeglumine).

"Stated another way, it means 8,000 times less gadolinium might be required for achieving good MRI results. Because very low gadolinium concentrations would be required for MRI, it could significantly decrease gadolinium toxicity, which is an important issue," explained Vitaliano. "Clathrin transported gadolinium is therefore among the most potent, biocompatible contrast agents available."

These results in two different applications showed that clathrin offers substantial functionalization and transport flexibility. Purified clathrin nanoparticles could therefore serve as an appealing alternative to other medical nanoplatforms such as dendrimers, nanogels, solid lipid nanospheres, liposomes, and the like.

The rest is here:
McLean Report on nanotechnology that may enhance medication delivery and improve MRI performance

The University of Arkansas at Little Rock dedicated its new nanotechnology center Wednesday as state leaders hailed Arkansas' emergence in the industry.

The $15 million, 50,500-SF UALR Center for Integrative Nanotechnology Sciences (CINS) is five stories, and consists of offices, classrooms, conference rooms, labs, cold rooms and even a greenhouse. Construction began in June of 2010, and the center was financed mostly through bonds.

The CINS will serve as a point of collaboration between the state's research universities, specifically the nanotechnology research being conducted at the University of Arkansas for Medical Sciences and the system's flagship campus in Fayetteville. It will serve a crucial role in the partnership Gov. Mike Beebe made last year with the Food & Drug Administration establishing collaboration between Arkansas' research institutions and FDA's National Center for Toxicological Research at Jefferson.

Already, NCTR is partnering with local private firms that deal with nanotech applications. It is working with Little Rock's Vivione Biosciences (formerly Litmus Rapid-B) to commercialize research involving the detection of E coli and other pathogens.

The goal of the partnership is to advance nanotechnology through research and education, and to commercialize the technologies that come from it.

Beebe, 2nd District Rep. Tim Griffin, U.S. Sen. Mark Pryor and UA System president Donald Bobbitt were among the officials joining UALR chancellor Joel Anderson and center director and chief scientist Alex Biris for the dedication. John Boozman, Arkansas' junior U.S. senator, was scheduled to tour the facility Thursday.

The elected officials took turns praising UALR's "investment in the future."

Griffin cited the center's ability to attract future high-paying jobs to the state, its potential with national security, and its long-term impact on quality of life through the nanotech research being done in the areas of cancer treatment and other health-care applications.

"This will be an economic engine and a real source of job creation, here and in the private sector," he said.

[Link to this article]

See the original post here:
UALR Dedicates $15M Nanotechnology Center

FDA NEWS RELEASE

For Immediate Release: April 20, 2012 Media Inquires: Curtis Allen, 301-796-0393, curtis.allen@fda.hhs.gov Consumer Inquiries: 888-INFO-FDA

FDA issues draft guidance on nanotechnologyDocuments address use of nanotechnology by food and cosmetics industries

Two draft guidance documents that address the use of nanotechnology by the food and cosmetics industries were issued today by the U.S. Food and Drug Administration.

Nanotechnology is an evolving technology that allows scientists to create, explore, and manipulate materials on a scale measured in nanometers particles so small that they can not be seen with a regular microscope. The technology has a broad range of potential applications, such as the packaging of food or altering the look and feel of cosmetics.

The two draft guidance documents are: Guidance for Industry: Assessing the Effects of Significant Manufacturing Process Changes, including Emerging Technologies, on the Safety and Regulatory Status of Food Ingredients and Food Contact Substances, Including Food Ingredients that are Color Additives and Guidance for Industry: Safety of Nanomaterials in Cosmetic Products.

The food draft guidance describes the factors manufacturers should consider when determining whether changes in manufacturing processes, including those involving nanotechnology, create a significant change that may:

The cosmetic product draft guidance discusses the FDAs current thinking on the safety assessment of nanomaterials when used in cosmetic products.Key points include:

Both guidances encourage manufacturers to consult with the agency before taking their products to market. Such consultation can help FDA experts address questions related to the safety or other attributes of nanotechnology products, or answer questions about their regulatory status.

Strong science is critical to FDAs ongoing review of the products it regulates. FDA is investing in an FDA-wide nanotechnology regulatory science program to further enhance FDAs scientific capabilities, including developing necessary data and tools to identify properties of nanomaterials and assess the impact they may have on products.

View original post here:
FDA issues draft guidance on nanotechnology

WASHINGTON (AP) Regulators are proposing that food companies that want to use tiny engineered particles in their packaging may have to provide extra testing data to show the products are safe.

The Food and Drug Administration issued tentative guidelines Friday for food and cosmetic companies interested in using nanoparticles, which are measured in billionths of a meter. Nanoscale materials are generally less than 100 nanometers in diameter. A sheet of paper, in comparison, is 100,000 nanometers thick. A human hair is 80,000 nanometers thick.

The submicroscopic particles are increasingly showing up in FDA-regulated products like sunscreens, skin lotions and glare-reducing eyeglass coatings. Some scientists believe the technology will one day be used in medicine, but the FDA's announcement did not address that use.

The draft guidance suggests the FDA may require food companies to provide data establishing the safety of any packaging using nanotechnology.

Under longstanding regulations, companies aren't required to seek regulatory approval before launching products containing established ingredients and materials, such as caffeine, spices and various preservatives.

But FDA officials said Friday that foods and packaging containing nanoparticles may require more scrutiny.

"At this point, in terms of the science, we think it's likely the exemption does not apply and we would encourage folks to come in and talk to us," said Dennis Keefe, director of FDA's office of food additive safety.

Keefe said companies are studying whether nanoparticles can reduce the risk of bacterial contamination in certain foods. He said the agency is aware of just one food package currently on the market that uses nanoparticles but did not identify it. He said more are expected in coming years.

The FDA has previously stated its position that nanotechnology is not inherently unsafe; however, materials at the nano scale can pose different safety issues than do things that are far larger.

"This is an emerging, evolving technology and we're trying to get ahead of the curb to ensure the ingredients and substances are safe," Keefe said.

Read more here:
FDA outlines rules for nanotechnology in food

ROCKVILLE, MD--(Marketwire -03/27/12)- MarketResearch.com has announced the addition of the new report "Nanotechnology for Drug Delivery: Global Market for Nanocarriers" to their collection of Biotechnology market reports. For more information, visit http://www.marketresearch.com/Cientifica-Ltd-v2574/Nanotechnology-Drug-Delivery-Global-Nanocarriers-6856624/

Nanocarriers will account for 40% of a $136 billion nanotechnology-enabled drug delivery market by 2021. We forecast the total market size in 2021 to be US$136 billion, with a 60/40 split between nanocrystals and nanocarriers respectively, although developing new targeted delivery mechanisms may allow more value to be created for companies and entrepreneurs.

Of the 10 nanocarrier technologies studied, liposomes and gold nanocarriers account for 45% of the total addressable market. Liposomes will offer the largest addressable market ($15 billion) in 2021 while gold nanocarriers will see the highest compound annual growth rate (CAGR) -- 53.8% -- in the next decade.

Drugs are loaded into nanocarriers (also called nanoshells or nanoparticles, between 1 and 100 nm), then transported through the body to the target site. This kind of targeted drug delivery for the treatment of cancers is one of the most anticipated and discussed benefits of nanotechnology-enabled medicine as it offers a level of accuracy in delivering drugs that far surpasses present methods. Typically over 90% of a drug is wasted in the body, which leads to unwanted side effects. Modern chemotherapy bombards patients with drugs in the hope that tumorous cells will be destroyed. The lack of specificity of current drug delivery techniques mean patients' healthy cells are destroyed indiscriminately along with cancer cells.

Using nanotechnology to combat cancer is not new. Abraxane, the first nanoparticulate drug delivery product for the treatment of breast cancer, launched six years ago. There are now hundreds of new nanotech-based treatments under development, ranging from reformulation of existing drugs to enhance their efficacy to radical new "magic bullet" therapies.

The healthcare market is changing. We are seeing a paradigm shift away from blockbusters and a 'one-size fits all' approach to a more personalized medicine based on an individual's unique genome and immune response. The more scientists learn about the molecular causes for disease the more targeted and effective nanotechnology-enabled drug delivery therapies will become.

For more information, visit http://www.marketresearch.com/Cientifica-Ltd-v2574/Nanotechnology-Drug-Delivery-Global-Nanocarriers-6856624/

About MarketResearch.com

MarketResearch.com is the leading provider of global market intelligence products and services. With research reports from more than 720 top consulting and advisory firms, MarketResearch.com offers instant online access to the world's most extensive database of expert insights on global industries, companies, products, and trends. Moreover, MarketResearch.com's Research Specialists have in-depth knowledge of the publishers and the various types of reports in their respective industries and are ready to provide research assistance. For more information, call Veronica Franco at 240-747-3016 or visit MarketResearch.com.

Read the original post:
Market Research Forecasts Nanotechnology-Enabled Drug Delivery Market at $136 Billion by 2021

With strong representation from Israeli academia and industry, INNI is charged with setting national goals and priorities for advancing nanotechnology in Israel, creating long-range plans that fully exploit Israel's scientific and commercialcapabilities.

In the five years since declaring nanotechnology as a national priority, the field marked significant achievements. 88 world-class scientists immigrated to Israel and were accepted as faculty members at theuniversities. The number of junior scientists in the field (including post-doctorates) is 320, the number of doctoral students is about 800 and the number of masters students is more than 900. In the past three years over 6,000 scientific papers have been published where1170 of which resulted from collaboration between the universities.

The financial side is also impressive with$101 million invested in the last five years in basic equipment, in addition to 45 million invested in new infrastructure and facilities.

In these years therewere 625 collaborations between Israeli academia and industry (domestic and foreign), and 170 "success stories" in the form of startup companies and approved patents,with another704 patent filings.

Dan Vilenski, a member of the National Committee for Nanotechnology, says, "I believe we are on the correct path to turn Israel into a leading power in nanotechnology. The program's achievements prove:

In light of the achievements of the program during the first five years, it was decided to continue funding the program for another five years but with a change of emphasis. From a program designed to build applied nanoscience infrastructure as a foundation for academia and industry, the emphasis moves to focused R&D programs that can be applied to industrial applications within a reasonable time.

In order to accelerate establishment of industrial activity based on nanotechnology, the universitynanocenters have begun to employ industrialists / entrepreneurs whose role is to identify emerging opportunities at the nanocenters at the early stages,to identify strategic partners and to realize application of the emerging nanotechnologiesin industry.

About INNI

The INNI was established as a shared initiative of Israel's Forum for National Infrastructures for Research & Development (TELEM) and Israel's Ministry of Trade and Industry. The INNI Board of Directors is appointed by The Chief Scientist, Ministry of Industry, Trade & Labor. The INNI BoD operates out of The MAGNET Program at the Office of the Chief Scientist.

In 2007, it was decided to establish the area of a national priority projectwith the goal of creating researchinfrastructure at six universities that will be the basis for nano industries in Israel.A fundingmechanism was established using a triangle support model wherethe government, the university and private donationseach provide a third of theprogram funding.

More here:
5 Years of Nano-Technology as an Israeli National Project

Dublin - Research and Markets (http://www.researchandmarkets.com/research/8f3c56b6/nanotechnology_mar) has announced the addition of the "Nanotechnology Market Forecast to 2014" report to their offering.

In the coming years, nanotechnology is set to play a pivotal role in various industry segments. The evolving technology has already influenced a large number of industrial segments, and the economic activity generated from it has been high in magnitude and wide in scope. The nanotechnology-based products, which have had a huge impact on almost each industrial sector, are now entering the consumer market in a big way.

As per the findings of our latest report, increased applications of the technology in sectors like electronics, cosmetics, and defense, would propel the growth of the global nanotechnology market, which is anticipated to expand at a CAGR of about 19% during 2011-2014.

According to Nanotechnology Market Forecast to 2014, electronic companies are finding new ways of incorporating nanotechnology into consumer products like music systems and mobile phones in order to improve their processing capabilities. Similarly, the technology could help improve cosmetics by changing their physical properties.

We also observed that the use of nanotechnology in defense technologies provides enhanced performance at lower cost. Besides, the budding technology has revolutionalized dental care as it decreases the healing time and improves the Osseo-integration during dental implant. Our report discusses in detail these application areas and the key market trends.

Though nanomaterials would continue to dominate the nanotechnology market in the coming years, nano devices, comprising nanolithographic tools for manufacturing the next generation semi-conductors, are estimated to grow at a much faster rate than nanomaterials in near future.

The crucial country-level analysis, included in the comprehensive research, identified that the US is the world's most prominent nanotechnology market and will continue to enjoy the biggest pie of the global industry in the years to come, despite developing economies like China, Korea, India, and Brazil investing huge sums in the nanotechnology R&D. Our report elaborates the application areas and regulatory environment relating to nanotechnology in these countries, along with the patent analysis.

Companies Mentioned:

- Altair Nanotechnologies Inc.

- Nanophase Technologies Corporation

Continue reading here:
Research and Markets: Nanotechnology Market Forecast to 2014

ESPOO, Finland & WATERVLIET, N.Y.--(BUSINESS WIRE)--

Vistec Lithography Inc. (www.vistec-semi.com) announced today that Micronova Nanofabrication Centre (www.micronova.fi) has selected one of its electron-beam lithography systems. The leading nanotechnology laboratory in Finland aims to use Vistecs EBPG5000plusES for the design, development and fabrication of micro- and nanosystems. The cutting edge technology is specialized for multi-user environments and is therefore a future-proof match to the needs of Micronova.

At Micronova more than 360 employees and students of different facilities carry out research in diverse fields of nanotechnology. The Finnish institute aims to use the system for research in the fields of nanoelectronics, nanofabrication, microelectronics, nanophotonics and microfabrication. This state-of-the-art electron-beam lithography system gives us the possibility to continue future-proof research at the very highest level. But not only the characteristics of the system determined our decision also the long term experience of Vistec in this field of research were decisive, comments Dr. Veli-Matti Airaksinen, director of Aalto Nanofab at Micronova, the acquisition of the new system.

The Vistec EBPG5000pES is a high-performance lithography tool based on reliable and well-proven system architecture. The system is equipped for true 100kV / 1mm performance under regular electron-optical conditions with a wide capability for high throughput applications. Rainer Schmid, General Manager Vistec Lithography, Inc., explains further characteristics: Its electron-optical column, rated for acceleration voltages of 50 and 100kV, enables the EBPG5000pES to provide a spot size down to <2.2nm. On the other hand nano-lithography structures smaller than 8nm can easily be generated. Furthermore the system incorporates an interactive graphical user interface (GUI). With this feature we enable the use for diverse, multiuser environments such as used at huge research institutes like Micronova or universities.

Micronova is one of the most scientific nano-research institutes in Europe. Therefore we are glad to have come to this agreement, comments Schmid the order. By providing a steady growing number of advanced research institutes and universities with electron-beam lithography systems Vistec has demonstrated that its technology is state-of-the-art and best choice. Vistec is known for its great support to its customers. But not only do our customers benefit from the cooperation, we do it as well. Having such a strong connection to cutting edge research institutes like Micronova enables us to continue the development of our technology to the demands of an even wider target group.

Micronova

Micronova Nanofabrication Centre is Finlands National Research Infrastructure for micro- and nanotechnology, jointly operated by Aalto University and VTT Technical Research Centre of Finland. Micronovas activities extend from fundamental physics to device prototyping, applied research and small-scale manufacturing. Technologies developed at Micronova include nanoelectronic and photonic devices, MEMS sensors, particle and X-ray detectors and THz technology.

Aalto University

Aalto University is a new multidisciplinary science and art community merging the strengths of three universities in the fields of science, technology, economics, art and design. Aalto University's cornerstones are its strengths in education and research, and its goal is to become one of the world's top universities. Aaltos community includes 20,000 students as well as a staff of 4,700 of which 340 are professors.

VTT Technical Research Centre of Finland

Read this article:
Finnish Research Centre Selects Cutting Edge Nanotechnology from Vistec

NAPLES, Fla.--(BUSINESS WIRE)--

Industrial Nanotech, Inc. (Pink Sheets:INTK), an emerging global leader in nanotechnology based energy saving and sustainable solutions announced today that the Co-Founders are retiring ninety percent of their Preferred Stock.

This is part of an overall strategy to structure Industrial Nanotech, Inc. for potential application to a more senior stock exchange, stated Stuart Burchill, Co-Founder and CEO/CTO of Industrial Nanotech, Inc. Based on revenue projections for the upcoming quarters, a result of eight years of diligent effort, it is appropriate to begin execution of a responsible strategy to provide maximum benefit to shareholder value. This is one step in that continuing process.

For further information on Nansulate nanotechnology based coatings and sustainable solutions visit: http://www.nansulate.com.

About Nansulate

Nansulate is the Company's patented product line of award winning, specialty coatings containing a nanotechnology based material and which are well-documented to provide the combined performance qualities of thermal insulation, corrosion prevention, resistance to mold growth, fire resistance, chemical resistance and lead encapsulation in an environmentally safe, water-based, coating formulation. The Nansulate Product Line includes industrial, residential, agricultural and solar thermal insulation coatings. Additional information about the Company and its products can be found at their websites, (www.inanotk.com) and (www.nansulate.com). Blog: http://www.nansulate.com/nanoblog, Twitter: http://www.twitter.com/NanoPioneer, Facebook: http://www.facebook.com/Nansulate.

About Industrial Nanotech Inc.

Industrial Nanotech Inc. is a global nanoscience solutions and research leader and member of the U.S. Green Building Council. The Company develops and commercializes new and innovative applications for sustainable nanotechnology which are sold worldwide.

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic and business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.

Read this article:
Industrial Nanotech, Inc. Founders Retiring 90% of Their Preferred Stock

Dublin - Research and Markets (http://www.researchandmarkets.com/research/e0c7cab9/nanotechnology_in) has announced the addition of the "Nanotechnology in Health Care" book to their offering.

Nanotechnologies are among the fastest growing areas of scientific research, and this is expected to have a substantial impact on human health care, especially in biomedical applications and nanomedicine now and in the near future. In the present scenario, nanotechnology is spreading its wings to address the key problems in the field of nanomedicine and human health care by improving diagnosis, prevention, treatment, and tissue engineering.

This book provides an in-depth investigation of nanotechnology-based therapy and recent advancements in this field for revolutionizing the treatments for various fatal diseases, including cardiovascular and infectious diseases.

Key Features

- Covers significant applied aspects of nanotechnology with up-to-date information and its breakthrough in various fields of human health care

- Presents comprehensive coverage of the dominant technology in various aspects of human health, supported by excellent photographs, figures, and references

- Provides important information regarding a variety of topics that will influence improved nanomedicine and biomedical research

Readership

Advanced undergraduate- and graduate-level students in nanotechnology, nanobiotechnology; researchers in macromolecular science, nanosciences, nanotechnology, chemistry, biology, and medicine, especially those with an interest in drug delivery or cancer therapy.

Key Topics Covered:

See more here:
Research and Markets: Nanotechnology in Health Care. An In-Depth Investigation of Nanotechnology-Based Therapy

Nanotechnology and its use in drug development has been a growing area of investment in the U.S. and that growth has been mapped in an interactive infographic by the Project on Emerging Nanotechnologies.

The map lists nanotechnology companies and organizations across the country by specialties, such as medicine and health, materials, imaging and microscopy, electronics, tools and instruments, academic and government research, and associations.

Advertisement

The Philadelphia-based Nanotech Institute, formed by Ben Franklin Technology Partners of Southeastern Pennsylvania, along with Drexel University and University of Pennsylvania, received a reinvestment of $1.1 million from the Commonwealth. It is forging an alliance with another nanotechnology group in the western part of the state the Pennsylvania Nanomaterials Commercialization Center, which received $638,900 to assist small and startup companies with early stage prototype development projects.

Anthony P. Green, Ben Franklin director for the Nanotechnology Institute and vice president of technology commercialization in the life sciences for Ben Franklin, said in a statement that the number of company spinoffs, technology licenses and intellectual property assets have grown substantially in the past three years, exceeding the growth during the first 10 years of the institute. These activities are being reflected in real economic impact for the region in terms of job growth.

The Nanotechnology Institute has created more than 30 companies in the region, according to the statement, among them Keystone Nano, which has used nanotechnology to develop drug-delivery solutions for solid and nonsolid tumor cancers, and Leversense, which has developed a diagnostics platform.

Continued here:
Map illustrates scale of nanotechnology development across the U.S.

Nanotechnology develops materials at the molecular level, creating structures with the potential to dramatically advance a variety of fields such as energy, electronics, and medicine. But such materials may also have the potential to harm the environment and humans. In the meantime, only small steps have been taken in developing risk assessment tools and manufacturing standards.

In this uncertain environment, a committee created by the National Research Council (NRC)which is administered jointly by the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicineissued a report January 25 providing an approach for developing the research strategies and scientific infrastructure needed to address potential health and environmental risks of nanomaterials (http://tinyurl.com /6w7fd4v). The report was requested by Congress and sponsored by the Environmental Protection Agency.

Innovations in nanotechnologysuch as these arrays of nanowires, which can be used for biosensing and manipulating cellsare expected to bring advances in

Read the original here:
Committee Calls for Framework to Assess the Safety of Nanotechnology Materials [Medical News & Perspectives]

NEW YORK, March 19, 2012 /PRNewswire/ --Reportlinker.com announces that a new market research report is available in its catalogue:

Nanotechnology for Medical Diagnosticshttp://www.reportlinker.com/p0799334/Nanotechnology-for-Medical-Diagnostics.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Nanotechnology

Following on from our "Nanotechnology for Drug Delivery" series of reports we are turning the focus onto medical diagnostics with our latest report: "Nanotechnology for Medical Diagnostics"

Nanotech enabled medical diagnostics promise to improve just about everything that can be improved from a diagnostics point of view: earlier detection of disease, higher sensitivity, higher accuracy, higher throughput capability, more results per assay; time saving and cost-effectiveness.

As with our "Nanotechnology for Drug Delivery" series of reports, this report provides a market numbers for the nanotech enabled medical diagnostic market between 2000-2010 and a market forecast for the period 2011-2021.

Report Scope

Two sets of data are presented in this report:

The TAM growth for NMBD between 2000-2010;TAM forecast for NMBD between 2011- 2021.

Both sets of data are segmented into;

TAM (US$ millions, % share, and CAGR) for:

Originally posted here:
Nanotechnology for Medical Diagnostics